ZA948061B - Galanthamine derivatives a process for their preparation and their use as medicaments - Google Patents
Galanthamine derivatives a process for their preparation and their use as medicamentsInfo
- Publication number
- ZA948061B ZA948061B ZA948061A ZA948061A ZA948061B ZA 948061 B ZA948061 B ZA 948061B ZA 948061 A ZA948061 A ZA 948061A ZA 948061 A ZA948061 A ZA 948061A ZA 948061 B ZA948061 B ZA 948061B
- Authority
- ZA
- South Africa
- Prior art keywords
- compounds
- medicaments
- preparation
- galanthamine derivatives
- galanthamine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/137,444 US6316439B1 (en) | 1993-10-15 | 1993-10-15 | Galanthamine derivatives as acetylcholinesterase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA948061B true ZA948061B (en) | 1995-06-06 |
Family
ID=22477461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA948061A ZA948061B (en) | 1993-10-15 | 1994-10-14 | Galanthamine derivatives a process for their preparation and their use as medicaments |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6316439B1 (xx) |
| EP (1) | EP0649846B1 (xx) |
| JP (1) | JP2664343B2 (xx) |
| KR (1) | KR100227957B1 (xx) |
| CN (1) | CN1039910C (xx) |
| AT (1) | ATE211474T1 (xx) |
| AU (1) | AU696170B2 (xx) |
| CA (1) | CA2118172C (xx) |
| CZ (1) | CZ283731B6 (xx) |
| DE (1) | DE69429570T2 (xx) |
| DK (1) | DK0649846T3 (xx) |
| EG (1) | EG20726A (xx) |
| ES (1) | ES2170759T3 (xx) |
| FI (1) | FI108722B (xx) |
| IL (1) | IL111275A (xx) |
| NO (1) | NO307464B1 (xx) |
| NZ (1) | NZ264682A (xx) |
| PL (1) | PL177549B1 (xx) |
| PT (1) | PT649846E (xx) |
| RO (1) | RO114134B1 (xx) |
| RU (1) | RU2109743C1 (xx) |
| TW (1) | TW289754B (xx) |
| ZA (1) | ZA948061B (xx) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT403803B (de) | 1996-04-19 | 1998-05-25 | Sanochemia Ltd | Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln |
| EP2311463A1 (en) * | 1999-12-10 | 2011-04-20 | Bonnie M. Davis | Analogs of galanthamine and lycoramine as modulators of nicotinic receptors |
| JP2005503345A (ja) * | 2001-04-30 | 2005-02-03 | バイエル・コーポレーシヨン | 新規な４−アミノ−５，６−置換チオフェノ［２，３−ｄ］ピリミジン |
| US20030162770A1 (en) * | 2002-02-22 | 2003-08-28 | Davis Bonnie M. | Use of modulators of nicotinic receptors for treatment of cognitive dysfunction |
| US20040254146A1 (en) * | 2002-05-21 | 2004-12-16 | Nastech Pharmaceutical Company Inc. | Carboxylate salts of galantamine and their pharmaceutical use |
| US20050143350A1 (en) * | 2003-11-19 | 2005-06-30 | Seed John C. | Combination drug therapy to treat obesity |
| WO2005065662A1 (en) * | 2003-12-31 | 2005-07-21 | Actavis Group Hf | Solid dosage formulations of galantamine |
| CA2551946A1 (en) * | 2003-12-31 | 2005-07-21 | Actavis Group Hf | Immediate, controlled and sustained release formulations of galantamine |
| US20080045500A1 (en) * | 2004-07-01 | 2008-02-21 | Eisai R&D Management Co., Ltd. | Nerve Regeneration Stimulator |
| EP2425845A1 (en) * | 2004-12-23 | 2012-03-07 | Voyager Pharmaceutical Corporation | Acetylcholinesterase Inhibitors and leuprolide acetate for the treatment of Alzheimer's disease |
| PT1895994E (pt) * | 2005-05-13 | 2010-12-03 | Alza Corp | Sistema de administração de medicamentos de camada múltipla com barreira contra o fluxo de material do reservatório |
| US20080188510A1 (en) * | 2005-05-23 | 2008-08-07 | Eisai R & D Management Co., Ltd. | Novel methods using zonisamide |
| US20090253654A1 (en) | 2005-09-22 | 2009-10-08 | Galantos Pharma Gmbh | Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
| EP1937226A2 (en) * | 2005-09-23 | 2008-07-02 | Alza Corporation | Transdermal galantamine delivery system |
| ES2463715T3 (es) | 2008-04-14 | 2014-05-29 | Neurodyn Life Sciences Inc. | Derivados de galantamina como profármacos para el tratamiento de enfermedades del cerebro humano |
| CA2768668A1 (en) * | 2009-07-23 | 2011-01-27 | Shire Llc | Galantamine amino acid and peptide prodrugs and uses thereof |
| WO2015176069A2 (en) * | 2014-05-16 | 2015-11-19 | Synaptec Development Llc | CLEARANCE OF AMYLOID ß |
| EP4029867A1 (en) | 2021-01-13 | 2022-07-20 | Alpha Cognition Inc. | Solid forms of galantamine benzoate gluconate |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL122665B1 (en) | 1978-11-21 | 1982-08-31 | Edinen Zentar Chim | Process for preparing novel dienones of narvedine type and their derivatives |
| US4663318A (en) | 1986-01-15 | 1987-05-05 | Bonnie Davis | Method of treating Alzheimer's disease |
| US6150354A (en) * | 1987-01-15 | 2000-11-21 | Bonnie Davis | Compounds for the treatment of Alzheimer's disease |
| ATE411026T1 (de) * | 1987-05-04 | 2008-10-15 | Bonnie Davis | Mittel zur behandlung der alzheimer-krankheit |
| NL8800350A (nl) | 1988-02-12 | 1989-09-01 | Stichting Biomedical Research | Synthetische galanthamine-derivaten, werkwijze voor het bereiden daarvan, en farmaceutische samenstellingen. |
| DE69229781T2 (de) | 1991-05-14 | 2000-01-05 | Ernir Snorrason | Behandlung des ermüdungssyndroms mit cholinesteraseinhibitoren |
| US5153193A (en) | 1991-10-01 | 1992-10-06 | Hoechst-Roussel Pharmaceuticals Incorporated | Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs |
-
1993
- 1993-10-15 US US08/137,444 patent/US6316439B1/en not_active Expired - Lifetime
-
1994
- 1994-10-10 ES ES94115961T patent/ES2170759T3/es not_active Expired - Lifetime
- 1994-10-10 EP EP94115961A patent/EP0649846B1/en not_active Expired - Lifetime
- 1994-10-10 DK DK94115961T patent/DK0649846T3/da active
- 1994-10-10 AT AT94115961T patent/ATE211474T1/de active
- 1994-10-10 PT PT94115961T patent/PT649846E/pt unknown
- 1994-10-10 DE DE69429570T patent/DE69429570T2/de not_active Expired - Lifetime
- 1994-10-13 RU RU94036745A patent/RU2109743C1/ru active
- 1994-10-13 FI FI944823A patent/FI108722B/fi not_active IP Right Cessation
- 1994-10-13 NZ NZ264682A patent/NZ264682A/en not_active IP Right Cessation
- 1994-10-13 IL IL11127594A patent/IL111275A/xx not_active IP Right Cessation
- 1994-10-14 TW TW083109527A patent/TW289754B/zh not_active IP Right Cessation
- 1994-10-14 CN CN94117062A patent/CN1039910C/zh not_active Expired - Lifetime
- 1994-10-14 PL PL94305457A patent/PL177549B1/pl unknown
- 1994-10-14 CZ CZ942545A patent/CZ283731B6/cs not_active IP Right Cessation
- 1994-10-14 ZA ZA948061A patent/ZA948061B/xx unknown
- 1994-10-14 RO RO94-01670A patent/RO114134B1/ro unknown
- 1994-10-14 KR KR1019940026305A patent/KR100227957B1/ko active IP Right Grant
- 1994-10-14 NO NO943895A patent/NO307464B1/no not_active IP Right Cessation
- 1994-10-14 CA CA002118172A patent/CA2118172C/en not_active Expired - Lifetime
- 1994-10-14 AU AU75813/94A patent/AU696170B2/en not_active Expired
- 1994-10-15 EG EG64694A patent/EG20726A/xx active
- 1994-10-17 JP JP6250777A patent/JP2664343B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA948061B (en) | Galanthamine derivatives a process for their preparation and their use as medicaments | |
| CA2333703A1 (en) | Isothiazole derivatives useful as anticancer agents | |
| CA2258548A1 (en) | Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases | |
| HU906402D0 (en) | Process for producing tricyclic carbapeneme derivatives an pharmaceutical preparatives containing these compounds as active substance | |
| EP0437030A3 (en) | Use of 4-substituted imidazoles for lowering intraocular pressure | |
| ES8606282A1 (es) | Un procedimiento de preparar derivados de acidos quinolin- ynaftiridin-carboxilicos | |
| IL75115A (en) | 3-oxadiazolyl-beta-carboline derivatives,process for the preparation thereof and pharmaceutical compositions containing the same | |
| PL309874A1 (en) | Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives | |
| AU649882B2 (en) | Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs, a process for their preparation and their use as medicaments | |
| ZA932359B (en) | 3-Aminochroman spiro compounds processes for preparing them and pharmaceutical compositions containing them | |
| IL113780A (en) | Glucopyranoside benzothiophenes process for their preparation and pharmaceutical compositions containing them | |
| CS368890A3 (en) | Aminooligohydroxy derivatives inhibiting effects of renin, process for their preparation and a pharmaceutical containing them | |
| WO2000008006A3 (en) | Piperidine and piperazine derivatives, process for their preparation and pharmaceutical compounds containing them | |
| HUT45059A (en) | Process for producing abeoergoline derivatives | |
| AU657423B2 (en) | Novel piperidine derivatives and process for preparation thereof | |
| IL106934A (en) | Heteroarenylpiperazines a process for their preparation and pharmaceutical compositions comprising them | |
| MXPA99003849A (es) | Derivados 9a, 11b-deshidro de 9-oxima-3-ceto-6-0-metileritromicina. |